Free Trial
LON:HLN

Haleon (HLN) Share Price, News & Analysis

Haleon logo
GBX 371.80
-0.40 (-0.11%)
(As of 11/4/2024 ET)

About Haleon Stock (LON:HLN)

Key Stats

Today's Range
370.20
374.80
50-Day Range
371.30
397.20
52-Week Range
308.37
400.65
Volume
44.82 million shs
Average Volume
19.93 million shs
Market Capitalization
£33.61 billion
P/E Ratio
3,098.33
Dividend Yield
1.61%
Price Target
GBX 415
Consensus Rating
Buy

Company Overview

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
18th Percentile Overall Score

HLN MarketRank™: 

Haleon scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Haleon has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Haleon has received no research coverage in the past 90 days.

  • Read more about Haleon's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Haleon is 3,098.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 131.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Haleon is 3,098.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 130.23.

  • Price to Earnings Growth Ratio

    Haleon has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Haleon has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for HLN.
  • Dividend Yield

    Haleon pays a meaningful dividend of 1.61%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Haleon does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Haleon is 5,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Haleon's dividend.
  • Short Interest

    There is no current short interest data available for HLN.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Haleon this week, compared to 1 article on an average week.
  • Search Interest

    Only 4 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Haleon insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.74% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    43.88% of the stock of Haleon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Haleon's insider trading history.
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Stock News Headlines

Haleon: Tailwinds Are Mostly Priced In
What's Going On With Kenvue Stock Monday?
2 sentences that change everything you THOUGHT you knew about trading
If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.
Haleon To Buy Addl. 33% Stake In China JV, Totaling 88%
Analysts agree that Kenvue's Neutrogena needs a face-lift
See More Headlines

HLN Stock Analysis - Frequently Asked Questions

Haleon's stock was trading at GBX 321.65 at the beginning of the year. Since then, HLN stock has increased by 15.6% and is now trading at GBX 371.80.
View the best growth stocks for 2024 here
.

Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Haleon investors own include GSK (GSK), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Meta Platforms (META) and Unilever (ULVR).

Company Calendar

Ex-Dividend for 9/19 Dividend
8/15/2024
Dividend Payable
9/19/2024
Today
11/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Consumer Goods
CIK
N/A
Fax
N/A
Employees
25,408
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 415
High Stock Price Target
GBX 447
Low Stock Price Target
GBX 383
Potential Upside/Downside
+11.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
£1.09 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£11.26 billion
Cash Flow
GBX 16.93 per share
Book Value
GBX 182 per share

Miscellaneous

Outstanding Shares
9,040,000,000
Free Float
N/A
Market Cap
£33.61 billion
Optionable
Not Optionable
Beta
0.19
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (LON:HLN) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners